HOME
NKCL BIO
Company/Business
CEO Profile
Organization
Company Introduction Video
Patents
Awarded
NK Cell
NK Cell
Mechanism of NK Cell
Competitiveness
NKCL Automated Cell Culture System
Process of NK Cell Therapy
Characteristics of NK Cell Therapy
Research field
Clinical data
Process of Immune Care
Microbiome
Notice
News
EN
CN
KR
Videos
IR
Academic research
Academic research
Contact us
Contact us
Products
Products
NKCL mall
NK shopping
Notice
News
- EN
- CN
- KR
Videos
IR
HOME / Notice / News /
EN
EN
NKCL Bio Group Wins Grand Prize as Auspicious Bio Firm in Korea’s Future Management Award
NKCL
2021.07.02 09:38
조회 2197
https://www.econovill.com/news/articleView.html?idxno=538945
In the 2021 Korea Future Management Award, NKCL Bio Group won the Grand Prize in Auspicious Bio Firm category, as hosted by Herald Economy and Korea Herald, and sponsored by Monthly Power Korea. This is their second consecutive win in the category, following last year’s win.
NKCL Bio Group uses an NK cell GMP automated cultivation system to provide personalized immunity care platform that corresponds to customers’ status and requests. In addition, they use microbiome technology to launch tech and products closely related to the daily life, introducing immune lifestyle and functional medicine solutions to customers.
On January 22, NKCL founded the Microbiome lab, where they use microbiome research data to make health supplements, cosmetics, and other food products to help customers improve immunity. They are also planning to build an NKCL intestinal microorganism inspection center. The advanced research technology and system of the U.S. will be introduced.
첨부파일
TBEnCj7pI.png
다운로드횟수[4008]
목록
다음글 |
NKCL Bio Group’s strategy to operate next generation personalized bio big data platform
이전글 |
NKCL Bio Group Sponsors Drama “Unless You’re Crazy”